BlackRock Fund Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$159M	Buy	873,392 +43,748	+5%	+$7.46M	0.03%	831
2016 Q3	$136M	Buy	829,644 +21,624	+3%	+$3.28M	0.03%	834
2016 Q2	$116M	Buy	808,020 +62,178	+8%	+$8.87M	0.03%	860
2016 Q1	$102M	Buy	745,842 +7,412	+1%	+$973K	0.02%	941
2015 Q4	$102M	Buy	738,430 +40,229	+6%	+$5.58M	0.02%	934
2015 Q3	$93.8M	Sell	698,201 -11,367	-2%	-$1.64M	0.02%	956
2015 Q2	$107M	Buy	709,568 +26,182	+4%	+$3.75M	0.03%	942
2015 Q1	$92.4M	Buy	683,386 +30,692	+5%	+$3.8M	0.02%	1067
2014 Q4	$78.7M	Buy	652,694 +7,510	+1%	+$864K	0.02%	1138
2014 Q3	$73.2M	Buy	645,184 +24,059	+4%	+$2.85M	0.02%	1088
2014 Q2	$74.4M	Buy	621,125 +50,199	+9%	+$6.13M	0.02%	1119
2014 Q1	$73.1M	Sell	570,926 -12,149	-2%	-$1.56M	0.02%	1103
2013 Q4	$72.1M	Buy	583,075 +15,253	+3%	+$1.86M	0.02%	1112
2013 Q3	$66.8M	Buy	567,822 +21,157	+4%	+$2.5M	0.02%	1085
2013 Q2	$61.3M	Buy	+546,665	New	+$64.1M	0.02%	1050